Developing Next-Generation in Vivo Cell and Gene Therapies
Oct 17, 2022•1 hr 7 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
David Johnson, founder and CEO of GigaMune, sits down with Neil to discuss his company's efforts to develop in vivo cell and gene therapies to treat cancer and autoimmune conditions.
For the best experience, listen in Metacast app for iOS or Android